Addex Therapeutics Ltd (ADXN.SW)
CHF 0.06
(-8.5%)
CHF 0.06
(-8.5%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.61 Million | 1.42 Million | 2.91 Million | 3.61 Million | 2.76 Million | 6.04 Million |
| Cost of Revenue | 6.93 Million | 14.62 Million | 12.81 Million | 10.37 Million | 230.09 Thousand | 144.16 Thousand |
| Gross Profit | -5.31 Million | -13.2 Million | -9.9 Million | -6.76 Million | 2.53 Million | 5.89 Million |
| Operating Expenses | 11.89 Million | 21.94 Million | 18.42 Million | 15.85 Million | 17.36 Million | 7.46 Million |
| Selling, General and Administrative Expenses | 4.86 Million | 7.29 Million | 5.13 Million | 5.14 Million | 4.26 Million | 4.71 Million |
| Research and Development Expenses | 2.74 Million | 14.66 Million | 12.84 Million | 10.37 Million | 12.45 Million | 2.36 Million |
| Other Expenses | - | -22.52 Thousand | 444 Thousand | 336.67 Thousand | 648.16 Thousand | 382.99 Thousand |
| Cost and Expenses | 11.92 Million | 21.94 Million | 18.42 Million | 15.85 Million | 17.36 Million | 7.46 Million |
| Operating Income | -10.31 Million | -20.52 Million | -15.5 Million | -12.24 Million | -14.83 Million | -1.42 Million |
| Interest Expense | 21.6 Thousand | 48.89 Thousand | 63.01 Thousand | 69.5 Thousand | 128.51 Thousand | 220.17 Thousand |
| Income Tax Expense | - | 264.36 Thousand | 63.01 Thousand | 69.5 Thousand | 128.51 Thousand | 1.00 |
| Earnings before Tax | -10.55 Million | -20.8 Million | -15.35 Million | -12.85 Million | -14.78 Million | -1.64 Million |
| Net Income | -10.55 Million | -21.06 Million | -15.41 Million | -12.92 Million | -14.9 Million | -1.64 Million |
| Earnings Per Share Basic | -0.14 | -0.47 | -0.45 | -0.48 | -0.56 | -0.07 |
| Earnings Per Share Diluted | -0.14 | -0.47 | -0.45 | -0.48 | -0.56 | -0.07 |
| Weighted Average Shares Outstanding | 74.3 Million | 45.18 Million | 34.11 Million | 26.68 Million | 26.39 Million | 23.29 Million |
| Weighted Average Shares Outstanding (Diluted) | 74.3 Million | 45.18 Million | 34.11 Million | 26.68 Million | 26.42 Million | 23.29 Million |
| Gross Margin | -3.29 | -9.28 | -3.40 | -1.87 | 0.92 | 0.98 |
| EBIT Margin | -6.32 | -14.18 | -5.20 | -3.27 | -5.15 | -0.24 |
| Profit Margin | -6.53 | -14.81 | -5.29 | -3.58 | -5.40 | -0.27 |
| EBITDA | -10.22 Million | -20.43 Million | -14.94 Million | -12.41 Million | -14.31 Million | -1.5 Million |
| Earnings Before Tax Margin | -6.38 | -14.43 | -5.32 | -3.39 | -5.37 | -0.24 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 115.27 Thousand | 234.91 Thousand | 183.82 Thousand | 1.61 Million | 327.73 Thousand | 630.87 Thousand |
| Cost of Revenue | - | -90.00 | 1.54 Million | 6.93 Million | 1.81 Million | 1.87 Million |
| Gross Profit | 115.27 Thousand | 235 Thousand | -1.36 Million | -5.31 Million | -1.48 Million | -1.24 Million |
| Operating Expenses | 1.01 Million | 1.02 Million | 2.78 Million | 11.62 Million | 2.98 Million | 3.17 Million |
| Selling, General and Administrative Expenses | 507.16 Thousand | 774.93 Thousand | 1.23 Million | - | 1.75 Million | 1.94 Million |
| Research and Development Expenses | 184.46 Thousand | 245.12 Thousand | 1.55 Million | - | 833.47 Thousand | 751.86 Thousand |
| Other Expenses | 322.96 Thousand | - | - | - | - | - |
| Cost and Expenses | 1.01 Million | 1.02 Million | 2.86 Million | 11.92 Million | 2.98 Million | 3.17 Million |
| Operating Income | -899.31 Thousand | -788.09 Thousand | -2.68 Million | -10.31 Million | -2.65 Million | -2.54 Million |
| Interest Expense | 864.00 | 611.00 | 8356.00 | 21.6 Thousand | 3503.00 | 3828.00 |
| Income Tax Expense | -14.86 Million | 3.08 Million | 5.00 | -2.00 | 3503.00 | 3828.00 |
| Earnings before Tax | -1.45 Million | -735.17 Thousand | -2.85 Million | -10.55 Million | -2.61 Million | -2.67 Million |
| Net Income | 12.87 Million | -3.08 Million | -2.85 Million | -10.55 Million | -2.61 Million | -2.67 Million |
| Earnings Per Share Basic | 0.13 | -0.03 | -0.03 | - | -0.03 | -0.04 |
| Earnings Per Share Diluted | 0.08 | -0.03 | -0.03 | - | -0.03 | -0.04 |
| Weighted Average Shares Outstanding | 98.3 Million | 97.53 Million | 95.23 Million | 74.3 Million | 77.27 Million | 72.18 Million |
| Weighted Average Shares Outstanding (Diluted) | 167.99 Million | 97.53 Million | 95.23 Million | 74.3 Million | 77.27 Million | 72.18 Million |
| Gross Margin | 1.00 | 1.00 | -7.41 | -3.29 | -4.52 | -1.97 |
| EBIT Margin | -11.42 | -3.34 | -14.16 | - | -7.82 | -3.90 |
| Profit Margin | 111.72 | -13.14 | -15.54 | -6.53 | -7.99 | -4.24 |
| EBITDA | -1.31 Million | -785.15 Thousand | -2.6 Million | - | -2.56 Million | -2.45 Million |
| Earnings Before Tax Margin | -7.80 | -3.35 | -14.59 | -6.38 | -8.09 | -4.04 |
CHRTEDCA
FF24
2475
8961
603976
CLIS